What are the side effects of Daratumumab?
Advertisement
- Bloating or swelling of the face, arms, hands, lower legs, or feet.
- chest pain or tightness.
- facial swelling.
- headache.
- puffiness or swelling of the eyelids or around the eyes, lips, or tongue.
- rapid, shallow breathing.
- skin rash, hives, or itching.
- slow or fast heartbeat.
What is Darzalex Faspro?
DARZALEX FASPRO is a combination of daratumumab, a CD38-directed. cytolytic antibody, and hyaluronidase, an endoglycosidase, indicated for the. treatment of adult patients with: • multiple myeloma in combination with bortezomib, melphalan and. prednisone in newly diagnosed patients who are ineligible for autologous.
How effective is Pomalyst?
Overall responses rates were 24% with Pomalyst and low-dose dexamethasone versus 4% with high-dose dexamethasone alone. On average, time without progression of myeloma was 3.6 months with Pomalyst and low-dose dexamethasone vs 1.8 months with high-dose dexamethasone alone.
Is Daratumumab a proteasome inhibitor?
Daratumumab is the first FDA-approved monoclonal antibody that targets CD38 that has demonstrated single-agent efficacy in patients with multiple myeloma who have received several previous treatments, including those whose disease is double-refractory to a proteasome inhibitor and an IMiD agent.
What is the difference between DARZALEX and DARZALEX Faspro?
What is Darzalex/Darzalex Faspro™? Darzalex, also known as daratumumab, is the first monoclonal antibody approved for use in multiple myeloma. Darzalex Faspro is a combination of daratumumab and hyaluronidase. Both drugs are made by Janssen Biotech.
How long can you take DARZALEX Faspro?
Darzalex Faspro may be prescribed for light-chain amyloidosis for up to 2 years, as long as the drug is safe and effective for you.
Is POMALYST a chemo?
Pomalyst® is the trade name for the generic chemotherapy drug pomalidomide. In some cases, health care professionals may use the generic drug name pomalidomide when referring to the trade name drug Pomalyst®.
How long can you take POMALYST?
Dosage for Kaposi sarcoma The usual dose of Pomalyst to treat Kaposi sarcoma (KS) is 5 mg once a day. You’ll likely take this dose on days 1 through 21 of your 28 day treatment cycle. Your doctor may have you stop taking Pomalyst if your KS gets worse or if side effects become too bothersome.
Is daratumumab an immunotherapy or chemo?
Darzalex contains daratumumab. This is a type of drug called a monoclonal antibody. Darzalex isn’t chemotherapy. It’s a type of biologic treatment and is sometimes called targeted therapy or immunotherapy.
How long is daratumumab effective?
Darzalex is administered until signs of progression of multiple myeloma (MM) occur, or side effects become intolerable. Treatment durations of up to 25 months have been reported in clinical trials (range 0.1 month to 40.44 months).
How long does daratumumab last?
Is DARZALEX Faspro covered by Medicare?
With the Janssen CarePath Savings Program for DARZALEX FASPRO®, eligible patients pay $5 for each dose for your medication costs, with a $20,000 maximum program benefit each calendar year. Not valid for patients using Medicare, Medicaid, or other government-funded programs to pay for their medications.
Is DARZALEX Faspro a chemo drug?
In some cases, health care professionals may use the trade name DARZALEX FASPRO or the generic name Daratumumab and Hyaluronidase when referring to the drug. Drug Type: Daratumumab and Hyaluronidase is an anti-cancer (“antineoplastic” or “cytotoxic”) drug.
Can DARZALEX cure multiple myeloma?
Although Darzalex cannot cure multiple myeloma it can improve the quality and length of life in most people. Unfortunately, there is currently no cure for multiple myeloma. However, the cancer can be managed successfully in many patients for years. Darzalex is a monoclonal antibody.